ENVALITH
コスモ・バイオ株式会社 logo

COSMO BIO COMPANY,LIMITED

3386Standard MarketWholesale Trade

コスモ・バイオ株式会社 logo
COSMO BIO COMPANY,LIMITED3386
Reference Indicators

Market Cap

75¥100M

P/E (Forecast)

P/B

0.7x

Dividend Yield (Forecast)

4.06%

ROE

3.6%

EV/EBITDA

9.3x
Financial Summary
Unit: ¥M
Item
2021Dec 2021
2022Dec 2022
2023Dec 2023
2024Dec 2024
2025Dec 2025
Net Sales
9,2319,5539,34010,03710,766
Cost of Sales
5,5726,1126,0906,7087,064
Gross Profit
3,6583,4403,2493,3293,702
SG&A Expenses
2,6092,6242,7293,0103,359
Operating Income
1,048816519318343
Non-operating Income
715713686158
Non-operating Expenses
208324012
Ordinary Income
1,099790653364489
Extraordinary Income
5369
Extraordinary Losses
4854
Pre-tax Income
1,099790653369504
Income Taxes
33023819199170
Net Income
737517442262337
EBITDA
1,214957667454510
Gross Margin
39.6%36.0%34.8%33.2%34.4%
Operating Margin
11.4%8.5%5.6%3.2%3.2%
ROA
7.3%5.0%4.1%2.2%2.7%
ROE
9.7%6.5%5.4%3.0%3.6%